198 related articles for article (PubMed ID: 2569708)
1. Amplification and rearrangement of c-erb B proto-oncogenes in cancer of human female genital tract.
Zhang X; Silva E; Gershenson D; Hung MC
Oncogene; 1989 Aug; 4(8):985-9. PubMed ID: 2569708
[TBL] [Abstract][Full Text] [Related]
2. Oncogene abnormalities in astrocytomas: EGF-R gene alone appears to be more frequently amplified and rearranged compared with other protooncogenes.
Burgart LJ; Robinson RA; Haddad SF; Moore SA
Mod Pathol; 1991 Mar; 4(2):183-6. PubMed ID: 1675468
[TBL] [Abstract][Full Text] [Related]
3. C-myc, N-myc, N-ras, and c-erb-B: lack of amplification or rearrangement in human medullary thyroid carcinoma and a derivative cell line.
Yang KP; Castillo SG; Nguyen CV; Hickey RC; Samaan NA
Anticancer Res; 1990; 10(1):189-92. PubMed ID: 2185686
[TBL] [Abstract][Full Text] [Related]
4. Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor.
Yamamoto T; Ikawa S; Akiyama T; Semba K; Nomura N; Miyajima N; Saito T; Toyoshima K
Nature; 1986 Jan 16-22; 319(6050):230-4. PubMed ID: 3003577
[TBL] [Abstract][Full Text] [Related]
5. Inverse relationship of epidermal growth factor receptor and HER2/neu gene expression in human renal cell carcinoma.
Weidner U; Peter S; Strohmeyer T; Hussnätter R; Ackermann R; Sies H
Cancer Res; 1990 Aug; 50(15):4504-9. PubMed ID: 1973362
[TBL] [Abstract][Full Text] [Related]
6. [The relation between prognosis and amplification of the c-erB-2 (HER-2/neu) proto-oncogene in ovarian carcinomas].
Fan QB; Bian ML; Huang SZ
Zhonghua Yi Xue Za Zhi; 1994 Nov; 74(11):683-5, 710. PubMed ID: 7866905
[TBL] [Abstract][Full Text] [Related]
7. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
[TBL] [Abstract][Full Text] [Related]
8. The c-erb B-2 proto-oncogene in human pancreatic cancer.
Hall PA; Hughes CM; Staddon SL; Richman PI; Gullick WJ; Lemoine NR
J Pathol; 1990 Jul; 161(3):195-200. PubMed ID: 2202801
[TBL] [Abstract][Full Text] [Related]
9. Oncogene patterns in breast and ovarian carcinomas.
Csókay B; Papp J; Besznyák I; Bösze P; Sárosi Z; Tóth J; Zalay Z; Oláh E
Eur J Surg Oncol; 1993 Dec; 19(6):593-9. PubMed ID: 7903645
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.
Guérin M; Barrois M; Terrier MJ; Spielmann M; Riou G
Oncogene Res; 1988; 3(1):21-31. PubMed ID: 2905033
[TBL] [Abstract][Full Text] [Related]
11. The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance.
Kohler M; Janz I; Wintzer HO; Wagner E; Bauknecht T
Anticancer Res; 1989; 9(6):1537-47. PubMed ID: 2697181
[TBL] [Abstract][Full Text] [Related]
12. ERBB2 (HER2/neu) oncogene is frequently amplified in squamous cell carcinoma of the uterine cervix.
Mitra AB; Murty VV; Pratap M; Sodhani P; Chaganti RS
Cancer Res; 1994 Feb; 54(3):637-9. PubMed ID: 7905784
[TBL] [Abstract][Full Text] [Related]
13. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
[TBL] [Abstract][Full Text] [Related]
14. Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue.
Yokota J; Yamamoto T; Miyajima N; Toyoshima K; Nomura N; Sakamoto H; Yoshida T; Terada M; Sugimura T
Oncogene; 1988 Mar; 2(3):283-7. PubMed ID: 3281095
[TBL] [Abstract][Full Text] [Related]
15. Amplification of the C-erbB-2(HER-2/neu) proto-oncogene in ovarian carcinomas.
Fan QB; Bian ML; Huang SZ; Lang JH; Ma J; Liu WS; Xu XY
Chin Med J (Engl); 1994 Aug; 107(8):589-93. PubMed ID: 7805442
[TBL] [Abstract][Full Text] [Related]
16. Expression of c-erbB-2 in human esophageal carcinoma cells: overexpression correlated with gene amplification or with GATA-3 transcription factor expression.
Shiga K; Shiga C; Sasano H; Miyazaki S; Yamamoto T; Yamamoto M; Hayashi N; Nishihira T; Mori S
Anticancer Res; 1993; 13(5A):1293-301. PubMed ID: 7902061
[TBL] [Abstract][Full Text] [Related]
17. Amplification, overexpression, and rearrangement of the erbB-2 protooncogene in primary human stomach carcinomas.
Park JB; Rhim JS; Park SC; Kimm SW; Kraus MH
Cancer Res; 1989 Dec; 49(23):6605-9. PubMed ID: 2573419
[TBL] [Abstract][Full Text] [Related]
18. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations.
Gaffey MJ; Frierson HF; Williams ME
Mod Pathol; 1993 Nov; 6(6):654-9. PubMed ID: 7905628
[TBL] [Abstract][Full Text] [Related]
19. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
Ram TG; Ethier SP
Cell Growth Differ; 1996 May; 7(5):551-61. PubMed ID: 8732665
[TBL] [Abstract][Full Text] [Related]
20. Expression of the c-erbB-2 gene encoding a growth factor receptor.
Yamamoto T; Akiyama T; Yokota J; Mori S; Toyoshima K
Princess Takamatsu Symp; 1986; 17():203-10. PubMed ID: 3455415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]